NCTM Studio Legale Associato assisted Yarpa and LBO France, leading private equity funds in Europe, in the sale of the entire share capital of IZO S.r.l. to Vaxxinova GmbH, a German company producing and marketing autogenous vaccines for farmed animals, care for the animals and GMP certified contract manufacturing of veterinary vaccines and antigens.

IZO is an Italian veterinary company founded within the Institute Zooprofilattico of Lombardia and Emilia Romagna regions in 1968, and acquired by Yarpa and LBO France in 2012.

Gleiss Lutz has advised major shareholder and CEO Alexander Margaritoff in connection with Tocos Beteiligung GmbH’s hostile takeover bid for Europe’s leading wine sellers Hawesko Holding AG. 

Baker & McKenzie advised Orkla ASA on its sale of 100 percent OJSC Orkla Brands Russia, a major Russian confectionery producer, to Slavyanka-Lyuks JSC, a member of Slavyanka, the Belgorod confectionery group. As part of the transaction, Baker & McKenzie also advised Orkla on the sale of its real estate property located in Yekaterinburg.

Renaissance Capital acted as Orkla’s exclusive financial advisor in this transaction.

DLA Piper has advised the wind turbine producer Senvion SE (formerly REpower Systems SE) on its sale by the Suzlon Group to the private equity investor Centerbridge Partners.

CMS Hasche Sigle is advising Japanese machine tool manufacturer DMG MORI SEIKI CO., LTD. (DMG MORI SEIKI CO) on all aspects of its voluntary public takeover offer to the shareholders of DMG MORI SEIKI AKTIENGESELLSCHAFT, Bielefeld (formerly: GILDEMEISTER AG) to acquire all the bearer shares. DMG MORI SEIKI CO announced its intention today via a company formed for this purpose (DMG MORI GmbH). With a stated offer price of EUR 27.50 per share, the transaction has a maximum total value of around EUR 1.640 billion.

Gilead Sciences, Inc. has acquired the FXR development programme from Phenex Pharmaceuticals AG. The programme comprises patented small molecule FXR agonists for the treatment of non-alcoholic steatohepatitis (NASH) and other liver diseases.

Linklaters advises Suzlon on the disposal of its German affiliate Senvion. The buyer is the US Investment Funds Centerbridge Partners. The closing of the transaction is subject to regulatory approvals.

Suzlon is one of the world’s leading producer of wind energy plants and based in Pune, India. The company offers a complete supply chain and has installed plants in North and South America, Asia, Australia, Europa and Africa. Suzlon had acquired Senvion, formerly known as Repower, in 2007 with the support of the same Linklaters team.

South-African Santova Group has acquired MASTERFREIGHT Internationale Spedition GmbH (MASTERFREIGHT) by way of a share deal. GvW Graf von Westphalen has advised the founders of MASTERFREIGHT on the sale in the course of the succession planning for the family business.

MASTERFREIGHT is a service provider in the logistics industry specialized in worldwide imports and exports. The firm which is based in Kelsterbach particularly focuses on transport solutions for South Africa.

A Dechert LLP Franco-American team led by Alain Decombe and Anne-Charlotte Rivière advised the shareholders of Trophos, a French privately held biotechnology company, in its buy back by Roche Group, a Swiss global health-care company. Roche, looking to expand their research of neuromuscular diseases, sought Trophos’s recent developments in the production of Olesoxime, an investigational medicine used as treatment for patients with spinal muscular atrophy.

Heuking Kühn Lüer Wojtek advised Oakley Capital Private Equity and Bellaxa AG on the sale of intergenia group to HEG Co. Ltd. (Host Europe), which is part of Cinven's portfolio.